A week after Endo Pharmaceuticals Inc., agreed to pay $10 million and donate another $1 million in prescription medications to settle a lawsuit with two Ohio counties suing opioid manufacturers for escalating the opioid epidemic in their communities, Allergan PLC announced it would pay $5 million to the counties to settle similar claims.
Under the settlement agreement, Allergan would pay $1.9 million to Summit County and $3.1 million to Cuyahoga County, an arrangement that allows it to be removed as a defendant in the Oct. 21 bellwether trial in a federal multidistrict litigation (MDL).
Allergan also said that it hasn’t actively marketed any of its opioids since 2013, and sold its generic opioid assets to Teva Pharmaceuticals in 2016.
The trial brought by Cuyahoga and Summit counties is the first among thousands in the multidistrict litigation seeking to hold drug companies accountable for their role in escalating the opioid crisis. Both Endo and Allergan are relatively small players in the opioid MDL, compared to pharmaceutical giants Purdue Pharma (makers of Oxycontin) and Johnson & Johnson. But the settlements are still an important move in the large and complex MDL.
Beasley Allen’s opioid litigation team includes these lawyers: Rhon Jones, Parker Miller, Ryan Kral, Rick Stratton, Will Sutton and Jeff Price. This team represents the State of Alabama, the State of Georgia, and numerous local governments, as well as other entities in opioid multdistrict litigation (MDL). They also handle individual claims on behalf of victims.